Abstract: Receptive anal intercourse and its association with sexually transmitted infections and human papillomavirus-related anal dysplasia has been well studied in various at-risk groups including men who have sex with men. However, the relationship between receptive anal intercourse and its potential complications in patients with inflammatory bowel disease is not fully understood. This narrative review discusses sexually transmitted infections and anal dysplasia in patients with inflammatory bowel disease who engage in receptive anal intercourse and the lack of evidence-based data to guide clinical practice. It addresses the psychosocial effects of stigmatization in these patients and its consequences in the clinical encounter. We review the need for sufficient data on infection, cancer prevention, and precoital and postcoital hygienic practices with hopes that future studies establish standardized guidelines and recommendations. Key Words: inflammatory bowel disease, receptive anal intercourse, anal dysplasia, sexually transmitted infection R eceptive anal intercourse (RAI) is commonly practiced among patients of all sexual orientations. However, the negative stigmatization by society and health care professionals leads to a persistent underreporting of RAI. 1,2 RAI and its association with sexually transmitted infections (STIs) and human papillomavirus (HPV)-related anal dysplasia are well documented in various atrisk groups, most notably in HIV-positive men who have sex with men (MSM). [1] [2] [3] [4] Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract. Studies have shown that patients with IBD are at an increased risk for anal dysplasia and anal intraepithelial neoplasia. 2 It is possible that chronic inflammation and its complications, including fistulas, fissures, and mucosal ulcerations, expose the lymphoid-rich anorectal tissue to increased rates of pathogen transmission. Therefore, patients with IBD engaging in RAI may present a greater risk for STIs, anal dysplasia, and intraepithelial neoplasia. However, there are no clear guidelines for STI and anal dysplasia screening in this cohort.
R eceptive anal intercourse (RAI) is commonly practiced among patients of all sexual orientations. However, the negative stigmatization by society and health care professionals leads to a persistent underreporting of RAI. 1,2 RAI and its association with sexually transmitted infections (STIs) and human papillomavirus (HPV)-related anal dysplasia are well documented in various atrisk groups, most notably in HIV-positive men who have sex with men (MSM). [1] [2] [3] [4] Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract. Studies have shown that patients with IBD are at an increased risk for anal dysplasia and anal intraepithelial neoplasia. 2 It is possible that chronic inflammation and its complications, including fistulas, fissures, and mucosal ulcerations, expose the lymphoid-rich anorectal tissue to increased rates of pathogen transmission. Therefore, patients with IBD engaging in RAI may present a greater risk for STIs, anal dysplasia, and intraepithelial neoplasia. However, there are no clear guidelines for STI and anal dysplasia screening in this cohort.
MSM, defined as men who engage in sexual intercourse with other men regardless of sexual orientation, often do not disclose their sexual practices, as historically they have been poorly supported in health care interactions. 5 Furthermore, women spanning various demographic categories engaging in RAI often underreport such sexual practices for fear of stigmatization. 1, 2 Failure to disclose these sexual practices often hinders medical advice on infection prevention and hygienic practices surrounding anal intercourse for both MSM and heterosexual patients. Open discussions with providers are especially important when a patient with IBD has active rectal or anal inflammation, perianal complications, or disease-related postsurgical changes. For patients, reliable adviceexclusive to MSM and should be evaluated in heterosexual populations as the incidence of STIs is significantly higher for RAI compared with other sexual practices. 1 Although it is not proven, one possible theory includes differences in the inherent qualities of the cervicovaginal and anorectal mucosae. In comparison to the cervicovaginal tissue, the anorectal mucosa is not rich in immunoprotective secretions and is at greater risk for traumatic abrasions. 1 Very few studies have investigated the link between RAI and STIs in heterosexual populations with even fewer studies evaluating other at-risk groups. 7 MSM and heterosexual women with IBD engaging in RAI may be among those at greater risk of STI transmission, as the inflammatory process compromises the integrity of an already highly receptive anorectal tissue. Evaluating a relationship between RAI and STIs in patients with IBD is crucial, as this may allow health care professionals to identify, better care for, and recommend preventive measures for at-risk patients with IBD. Such identification is important as often it is difficult to distinguish between rectal and pouchitis STIs, IBD flares, or the coexistence of both processes.
Both IBD and STIs are common causes of rectal inflammation, also known as proctitis, and are often indistinguishable. Infectious causes of proctitis include Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus, Treponema pallidum, and lymphogranuloma venereum. Histologically, STIs and IBD share similar features ( Figs. 1 and 2) . In a study performed by Soni et al, 8 IBD and the chlamydial infection lymphogranuloma venereum were found to have substantial histological overlap, and differentiating between the 2 relied heavily on clinical suspicion in patients with risk factors for either disease. Furthermore, when evaluating inflammatory colorectal biopsies in patients with new or known diagnosis of IBD, pathologists should also consider STIs on the differential as history of at-risk behavior is often not provided. 8 Like untreated lymphogranuloma venereum, IBD can lead to inflammation and ulcerations of the anorectal canal increasing susceptibility to STI transmission. 8 If a history of RAI is not elicited from patients with proctitis and known or suspected IBD, rectal STI testing may not be considered until patients fail multiple courses of IBD treatment. At this point, alternate or concurrent antibiotic therapy may be delayed, potentially triggering or exacerbating flares and causing treatment failure in those with underlying IBD. 8 Although not proven, rectal STI transmission may be higher during flares, potentially precipitating flares and preventing remission by exacerbating mucosal inflammation and slowing mucosal healing.
It support this theory and the utility of routine rectal STI screening in at-risk patients with IBD on immunosuppressive therapies.
Currently, in MSM, the Centers for Disease Control recommends at least annual rectal, urethral, and pharyngeal screening for STIs and up to every 3 months in MSM with multiple sexual partners and HIV infection (Table 1) . Although previous studies have shown that infectious proctitis is more prevalent among women than commonly believed, there are currently no clear guidelines for rectal STI screening among women or populations such as patients with IBD who engage in high-risk sexual activities such as RAI. 9, 10 As there are no guidelines or recommendations, it is up to individual physicians to obtain a detailed sexual history, including a history of RAI, and use their discretion when considering rectal screening in these high-risk patients with IBD. Although it is not evidenced-based, Table 1 provides preferred diagnostic testing based on our clinical practice. 11 
ANAL DYSPLASIA AND ANAL CANCER RISK IN PATIENTS WITH IBD WHO ENGAGE IN RAI
Both cervical and anal dysplasia are associated with HPV and are precursor lesions for HPV-related malignancies. 2 Known risk factors for anal dysplasia include smoking, RAI, and multiple sexual partners (Table 2) . 2, 3 The prevalence of anal dysplasia has been found to be 10-to 100-fold higher in some immunosuppressed populations, including HIV-positive patients, kidney transplants recipients, and patients with solid organ tumors. 2, 4, 12 Among patients with HIV, for example, RAI has been shown to be an independent risk factor for the development of anal dysplasia with an odds ratio of 3.03. 13 Although immunosuppression is a known risk factor for anal dysplasia, Patel et al 14 demonstrated RAI to be a significant contributor to the development of HPV-related anal dysplasia in kidney transplant patients on immunosuppressive therapy. Interestingly, 4.6% of the study population (5 patients) reported a history of RAI. 14 Data on the prevalence of anal dysplasia in patients with IBD taking chronic immunosuppressive therapy and engaging in anal intercourse is however limited.
Shah et al compared the prevalence of anal atypical squamous cell of undetermined significance in immunosuppressed patients with IBD compared with both nonimmunosuppressed patients with IBD and healthy controls and found no difference with respects to immunosuppressive status (odds ratios 1.1 and 3.7, respectively). 2 Although not statistically significant, more studies are needed to assess the clinical implications of these findings.
Risk factors for cervical dysplasia are well documented in women, which has led to standardized screening guidelines and significant reductions in cervical cancer incidence and mortality. 15 Further studies have been designed to identify most-at-risk populations of women. Women with systemic lupus erythema on long-term immunosuppressive therapy, immunosuppressed transplant and cancer patients, and women with IBD were among those demonstrated to be at higher risk of HPV infection and cervical dysplasia. 2, 16 Specifically, women with IBD had a higher incidence of abnormal cervical Pap smears, and there was a further increased risk in those patients on immunosuppressive therapy. 16 In a meta-analysis by Allegretti et al, 17 women with IBD on immunosuppressive therapy were at an increased risk of developing high-grade cervical dysplasia and cervical cancer compared with healthy controls. In another study by Rungoe et al, 18 women with IBD, independent of treatment regimen, were at an increased risk of developing cervical dysplasia, with CD patients treated with tumor necrosis factor alpha being at an even greater risk. RAI is a known risk factor for anal dysplasia and intraepithelial neoplasia. In a study by Shah et al, 2 women with longstanding CD were 4.8 times more likely to have an abnormal anal Pap smear. It has been speculated that reductions or mutations in immune defense proteins in the gastrointestinal Paneth cells, specifically seen in patients with CD, may be responsible for the increased susceptibility to contract HPV and develop atypical squamous cell formation. 2 RAI in patients with IBD may disrupt the integrity of the anal mucosa, placing these patients at heightened risk due in part to direct contact with an HPV infectious source and a compromised immune response secondary to autoimmune dysregulation. Furthermore, in a study performed by Holly et al, 19 patients with hemorrhoids, fissures, or fistulas were found to be at an increased risk for anal cancer thought to be secondary to irritation, chronic inflammation, and repeated cellular regeneration of the anal mucosa. Therefore, we speculate that patients with IBD are also at high risk for developing anal dysplasia because of their predisposition for gastrointestinal tract inflammation and disease-related complications such as fistulas and fissures.
These theories suggest a relationship between traumatic abrasions, immunoregulation, and HPV-related dysplasia. In patients with IBD on immunosuppressive therapy, RAI may be a confounding factor increasing the risk of anorectal dysplasia in patients with known immune dysregulation and a potentially inhibited ability to defend against viral illnesses. 2 More studies of patients with IBD who engage in RAI are needed to assess the utility of anal dysplasia screening in this population.
SCREENING FOR ANAL DYSPLASIA
Screening guidelines for cervical dysplasia have greatly decreased the incidence of cervical cancer and similar guidelines may provide some benefit in risk reduction for anal cancer as well. No national guidelines for anal dysplasia exist, and there is no general consensus among national societies. However, if patients have access to appropriate follow-up for positive results, physicians should consider screening high-risk groups including all HIV-positive patients, HIV-negative MSM, patients with a history of cervical cancer, vulvar cancer, or high-grade vulvar squamous intraepithelial neoplasms. 20 Women engaging in RAI and men and women with anal condyloma should also be considered. 20 Screening modalities include digital rectal examination, anal Pap smear test, and high-resolution anoscopy. Some experts including the American Cancer Society suggested that anal Pap smear screening be performed every 2 to 3 years in HIV-negative patients and annually in HIV-positive patients. 20 Even in these high-risk patients, screening is infrequently performed because of provider discomfort with discussing and performing anal Pap smears, patient reluctance to undergo anoscopy, and the lack of sufficient data to support a survival benefit with routine screening. Early detection of anal cancer in high-risk groups may lead to improved survival outcomes, as prognosis strongly correlates with the clinical stage of the disease: there is greater survival benefit with localized disease as compared to regional or distant metastasis. 21 Larger trials are needed to examine whether there is a survival benefit with routine anal Pap smears in at-risk populations.
PSYCHOSOCIAL ISSUES SURROUNDING PA-TIENTS WITH IBD WHO ENGAGE IN RAI
IBD is a chronic illness that can negatively affect many facets of a patient's life. Flares can be debilitating and unpredictable, causing substantial psychosocial stress for patients. Patients with IBD are prone to social isolation, body-related disorders, sexual dysfunction, and anxiety. 22 Sexual practices including RAI that can directly impact the physical and psychological course of the disease are often not discussed between providers and patients. 22 Both MSM and heterosexual women are often reluctant to disclose anal intercourse, especially in societies and health care systems where RAI is not routinely addressed. In a study by Shah et al, 24% of women reported a history of RAI, with rates ranging from 6% to 46% in other studies. 1, 2 In an article published by Dibley et al, 14 gay men with IBD were interviewed and expressed concerns that others assume a relationship between their sexual behavior and IBD, making it difficult to disclose their sexual identity. 5 This is particularly important as gay and bisexual patients regardless of IBD status are poorly supported in health care with a reported moderate-to-severe rate of psychological distress. 23 In the study by Dibley et al, 5 a gay patient with IBD testified "the only concern I ever have really is that people may judge and think [IBD] is related to being gay and the whole anal sex thing." Although this perception may serve as a barrier to disclosing sexual preferences, many gay patients with IBD reported that waiting for an opportunity to be presented to disclose sexual identity was a frequently used strategy. 5 Patients with IBD who engage in RAI may have unique issues including psychological and illnessrelated concerns that require additional support. Health care providers should provide patients with IBD a safe space to discuss sexual identity, sexual practices, and the impact IBD may have on these issues. A thorough sexual history of patients with IBD is particularly important and should include whether patients engage in sexual practices with partners of any gender and whether they participate in RAI.
Patients with IBD who engage in anal intercourse, regardless of orientation, lack specific advice on sexual practices in relation to their IBD. An informal perusal of internet blogs revealed that patients rely on patient initiated web-based groups and resources for support and to gain insight on the frequently asked questions about RAI while living with IBD. Questions were varied and included the following: Is RAI prohibited when diagnosed with IBD? Should RAI be avoided in certain IBD phenotypes or disease patterns? How do complications like abscesses, fissures, or fistulas affect one's ability to have RAI? What precautions should be taken before and after RAI? How to engage sexual partners in a discussion regarding RAI and IBD? 24 The advice shared among these groups was largely variable and often based on personal experiences, speculations, or a single physician's advice. Studies are needed to address specific health and psychosocial issues to advise safe sexual practices among patients with IBD.
POSTSURGICAL ISSUES IN PATIENTS WITH IBD WHO ENGAGE IN RAI
Currently, there is no published data on the risk and limitations of RAI in postsurgical patients with IBD. In a study performed by Dibley et al, 5 gay and lesbian patients reported that postsurgical guidance on RAI was lacking, especially after ileal pouch-anal anastomosis (IPAA). Creation of a pouch or the presence of perianal CD made anal intercourse difficult or unpleasurable for MSM patients. For example, a respondent testified that he felt "robbed of the choice, robbed of that flexibility within [his] sex life." 5 A respondent also noted that the postsurgical information leaflets that were distributed did not cover RAI despite having a section on sex and relationships. 5 Several of the more common surgical operations altering anorectal anatomy in IBD involve formation of the IPAA and ileorectal anastomosis, both of which can negatively impact RAI. In patients with an IPAA, the rectum is removed and the ileum is attached to the opening of the anus. Because of decreased elasticity and adaptability of the ileum in comparison with the rectum, RAI may be more difficult in patients with an IPAA. RAI in these patients increases the risk of damage to the suture lines and tearing or rupturing of the intestinal wall. In patients with ileorectal anastomosis, the rectum is preserved making RAI more feasible with positional manipulations. However, as RAI can trigger or worsen proctitis, bloggers have reported that sex is far too painful in these patients. 24 Recommendations for anal intercourse in postsurgical patients vary widely among providers as there is no evidencebased data to address the risk or limitations associated with RAI. For instance, in patients with IBD who underwent IPAA with preserved anal transitional zone, the risk of developing dysplasia at the anal transitional zone is low; however, how RAI may alter this risk is unknown. 25, 26 Studies are needed to assist providers in facilitating discussions surrounding safe sexual practices in this population before nonemergent surgery.
HYGIENIC PRACTICES AMONG PATIENTS WITH IBD WHO ENGAGE IN RAI
Rectal hygiene including enema usage or douching, rectal microbicides, laxative cleansers, and lubrication are common practices in preparation for anal intercourse, especially among MSM. Enemas or douching are hygienic practices to clean the rectum before RAI. The evidence is not clear, but studies have shown that some enemas, including tap water and soapsuds, can Silicon-based and water-based iso-osmolar lubricants are preferred agents. Routine precoital rectal douching or enemas are not recommended.
In patients who will engage in douching or enemas regardless of physician advice, we recommend using a bulb syringe with tap water without connection to a pressurized system (such as a shower faucet).
CT, Chlamydia trachomatis; IPAA, ileal pouch-anal anastomosis; NG, Neisseria gonorrhoeae..
lead to damage to the rectal mucosa and surface epithelial loss. 27, 28 It is theoretically possible that douching before or after RAI could trigger IBD flares and increase the risk of STIs, especially during unprotected intercourse, although this has never been demonstrated. Commonly cited reasons for rectal douching before or after RAI included cleanliness, advice from friends, request by sexual partners, and STI prevention. 28 The use of lubricants also appeared to be a common practice on internet blog reviews with an unclear potential relationship to IBD. In a study performed by Fuchs et al 29 comparing water-based isosmolar and hyperosmolar lubricants, epithelial breakdown was greater in hyperosmolar lubricants. In a study by Dezzutti et al, 30 silicon-based and nearly isoosmolar lubricant showed no significant epithelial modifications. Furthermore, neither water-based nor silicone-based lubricants were associated with an increase in HIV-1 infection. 30 However, more studies are needed to investigate whether the use of lubricants may predispose to flares or STI transmission in patients with IBD engaging in RAI.
Fiber supplements and laxatives are also used as cleansers before RAI, but these may be less used options in patients with active IBD or in postsurgical patients where frequency and incontinence may be issues. 31 Postcoital rectal steroids were also mentioned as a way to reduce pain, inflammation, and prevent IBD flares. 32 However, the effectiveness of their utility in preventing flares and its implications in the transmission of sexual transmitted diseases remains unclear.
CONCLUSION
RAI is not exclusive to MSM and is often considered a taboo topic of discussion. Patients with IBD engaging in RAI may be at greater risk of contracting STIs, developing HPVrelated anal dysplasia, and IBD flares. Physicians who care for patients with IBD should be aware of these risks and engage in a discussion about sexual practices including RAI during initial clinical encounters. Although not evidence based, Table 3 provides a summary of recommendations based on our expert opinions and clinical practices. This topic is in need of much more research to establish basic guidelines and recommendations for patients and practitioners regarding RAI and IBD. Future studies should survey disease-specific patient concerns, sexuality and sexual behavior, and what patients with IBD are doing to ensure safe sexual practices. Providers' input on the needs of their patients with IBD who engage in RAI and their personal recommendations and expert opinions are equally as crucial in establishing basic guidelines and recommendations and providing training modalities for health care professionals caring for these patients.
